Viatris Inc. (NASDAQ: VTRS) is a global healthcare and pharmaceutical company formed in November 2020 through the merger of Mylan and Upjohn, a legacy division of Pfizer. Headquartered in Canonsburg, Pennsylvania, Viatris develops, manufactures, and distributes a broad portfolio of branded, generic, complex generic, and biosimilar medicines across therapeutic areas, reaching patients in more than 165 countries and territories.